Experts tip 2 beaten up ASX shares for gains in 2022

Could AGL and A2 Milk really be buys for 2022?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Now that 2021 is fast approaching its expiration date, many investors will no doubt be turning their attention to 2022 and what the imminent year might hold for ASX shares. With the S&P/ASX 200 Index (ASX: XJO) returning roughly 10.4% year to date in 2021 so far (touch wood), we can say that it has been a relatively successful year for the sharemarket on the whole.

But, of course, not all ASX 200 shares had a great year. Two of the worst performers on the entire market have been A2 Milk Company Ltd (ASX: A2M) and AGL Energy Ltd (ASX: AGL).

As of today's pricing, AGL shares are down a nasty 51.4% year to date in 2021. A2 Milk shares fared even worse, losing more than 51.9% this year so far.

But could these ASX dogs stage a compelling turnaround as we venture into 2022?

Two ASX investing experts think so.

a man and a woman kneel in a boxing ring with exaggerated make-up injuries, posing in humorous stance with the woman leaning back on her knees and the man leaning against her bright pink boxing glove as he gasps for air.

Image source: Getty Images

ASX expert picks out AGL share price

A recent Livewire Interview with James Gerrish from Market Matters and Jun Bei Liu of Tribeca Investment Partners covered A2 Milk and AGL respectively. These analysts singled out the companies for a 2021 Christmas stocking pick. It made for some interesting reading, particularly for shareholders in the companies.

So here's what Mr Gerrish had to say on AGL:

I've certainly got one that's been depressed over the last 12 months. It's AGL Energy. It's down 53%. I think it's the fourth worst-performing stock on the ASX 200 this year.

A large portion of that drop is correct, but it now becomes an asset at play. So it is trading at around $5.50 a share. It's cheaper than its retail business. So that, for me, is a buy and [it] will do better in '22 than it did in '21.

So a definite 'buy' for AGL from Gerrish. No doubt that will be music to the ears of long-suffering AGL shareholders going into next year.

A2 Milk is "going to really recover in the next 12 months"

But what of A2? Here's what Jun Bei Liu had to say about A2 Milk shares:

A2 Milk is our name. I know it's a tough name and it has certainly polarised the market.

You can't go wrong with infant formula. A2 is a name we liked many years ago. It's got a great brand and it has established distribution channels into Asia. And it's got a business in the US and Australia market. It's got a good market position. Now, during the pandemic, they've been hurt by pantry stocking… But the good thing is that the company doesn't have any debt. It's sitting with close to $600 million of cash. 

It's still got a great brand and we're seeing green shoots in some of its distribution channels… Pricing is up and volumes are good. Green shoots are looking promising and it's clearly much cheaper than what it was. And the share price is still pretty much at an all-time low. My view is that it's going to really recover in the next 12 months.

So there you have it — a bull case for a good 2022 for both AGL and A2 Milk. No doubt investors will be keeping their fingers crossed that these bull cases play out.

Motley Fool contributor Sebastian Bowen owns A2 Milk. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week this Monday.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

Paper aeroplane going down on a chart, symbolising a falling share price.
Travel Shares

Why Web Travel shares are sliding as fresh takeover hopes return

Web Travel shares sink as investors weigh CEO succession and takeover risk.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »